Is Voltaren (diclofenac) a suitable treatment option for a 60-year-old diabetic lady with knee pain?

Voltaren (Diclofenac) Is Not Recommended for a 60-Year-Old Diabetic Patient with Knee Pain

Oral diclofenac (Voltaren tablets) is not recommended for this 60-year-old diabetic lady with knee pain due to significant cardiovascular and renal risks that outweigh potential benefits. 1

Risks of Oral NSAIDs in Diabetic Patients

Oral NSAIDs, including diclofenac, present several significant concerns for diabetic patients:

• Cardiovascular risk: Diclofenac has been shown to increase the risk of cardiovascular events with a relative risk of 1.63 (95% CI: 1.12-2.37) compared to placebo 1
• Renal complications: NSAIDs can cause dose-dependent reduction in renal blood flow, which may precipitate overt renal decompensation, particularly in diabetic patients 2
• Gastrointestinal risk: Age ≥60 years is an independent risk factor for NSAID-induced GI complications 2

Better Treatment Options for This Patient

1. First-line options:

• Acetaminophen (up to 4g/day) - safer cardiovascular and renal profile 3
• Topical NSAIDs - specifically topical diclofenac gel provides effective pain relief with minimal systemic absorption 3, 4, 5

2. For neuropathic pain component (if present):

• Pregabalin or duloxetine are recommended as first-line treatments for diabetic neuropathic pain 6, 7
• Gabapentin is an alternative option with good evidence 7

Treatment Algorithm for Knee Pain in Diabetic Patients

1. Assess pain type:

   • Mechanical/inflammatory pain: Start with topical NSAID (diclofenac gel)
   • Neuropathic pain features: Consider pregabalin or duloxetine 6

2. If topical treatment insufficient:

   • Add acetaminophen (≤4g/day) 3
   • Consider intra-articular corticosteroid injection for short-term relief 3

3. For persistent pain:

   • Physical therapy and appropriate orthoses
   • Consider referral for comprehensive diabetic foot evaluation 6, 8

Important Considerations and Monitoring

• Diabetic neuropathy assessment: Up to 50% of diabetic peripheral neuropathy may be asymptomatic but increases risk 6
• Renal function: Monitor creatinine if any systemic analgesics are used
• Foot examination: All diabetic patients should have comprehensive foot evaluations at least annually 8

Why Topical Diclofenac Is Preferred Over Oral

Topical diclofenac has demonstrated:

• Similar efficacy to oral NSAIDs for localized knee pain 5, 9
• Significantly lower systemic absorption (95% less than oral administration) 4
• Similar safety profile in patients ≥65 years compared to younger patients 4
• Primary side effects limited to minor local skin reactions rather than systemic complications 5, 10

Remember that pain management in diabetic patients requires careful consideration of cardiovascular and renal risks. The evidence clearly shows that topical NSAIDs provide a much safer alternative to oral diclofenac tablets while still offering effective pain relief for knee osteoarthritis.